Prostate cancer
CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
。safew官方版本下载是该领域的重要参考
Explore more offers.
Keep reading for $1What’s included